IMCC - IM Cannabis Corp.


1.3101
-0.060   -4.572%

Share volume: 6,445
Last Updated: 04-07-2025
Pharmaceutical Products/Medicinal Chemicals: -0.09%

PREVIOUS CLOSE
CHG
CHG%

$1.37
-0.06
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
15%
Profitability 0%
Dept financing 25%
Liquidity 0%
Performance 30%
Performance
5 Days
-13.81%
1 Month
-28.02%
3 Months
-37.32%
6 Months
-37.32%
1 Year
-37.32%
2 Year
-37.32%
Key data
Stock price
$1.31
P/E Ratio 
N/A
DAY RANGE
$1.30 - $1.49
EPS 
N/A
52 WEEK RANGE
$1.30 - $2.17
52 WEEK CHANGE
-$37.32
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$11,550
AVERAGE 30 VOLUME 
$8,890
Company detail
CEO: Oren Shuster
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

IM Cannabis Corp. engages in breeding, growing, and supply medical cannabis products. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers.

Recent news
loading